preprints.org > public health and healthcare > health policy and services > doi: 10.20944/preprints202407.2381.v1 (registering DOI)

Preprint Article Version 1 This version is not peer-reviewed

Version 1 : Received: 29 July 2024 / Approved: 29 July 2024 / Online: 30 July 2024 (07:25:03 CEST)

Pharmacist-prescribed hormonal contraception (HC) is supported by a majority of pharmacists and pharmacy students; however, few studies have evaluated perceptions of non-community pharmacists, or differences in geographic areas. The primary objective of this study is assess differences between community and non-community pharmacists in perceptions of pharmacist HC prescribing. Secondary objectives include assessment of community pharmacist interest in prescribing HC, and differences in perceptions between pharmacists in metropolitan and nonmetropolitan areas. A survey was emailed in early 2022 to 2592 Georgia pharmacists, with Likert questions assessing interest, perceptions, comfort, and perceived barriers regarding pharmacist prescribed HC. Completed survey response rate was 11.8%. Regardless of practice site, a majority agreed pharmacists are well-trained to prescribe HC (Community 61.8% vs. Non-community 68.1%, p=0.25) and provision of HC services is within the pharmacist’s scope (Community 73.6% vs. Non-community 74.2%, p=0.90). Overall metropolitan and non-metropolitan community pharmacists' perceptions were similar, however more metropolitan pharmacists believed pharmacists are well trained to prescribe HC (66.7% vs 48.7%, p=0.049) and that it is within their scope of practice (78.1% vs. 61.5%, p=0.045). In summary, the majority of pharmacists, regardless of practice type, believe that pharmacists are prepared to prescribe HC and it is a part of pharmacist’s professional scope of practice.

hormonal contraception; pharmacist; pharmacy access; pharmacist-prescribed

Public Health and Healthcare, Health Policy and Services

* All users must log in before leaving a comment